Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Asia Pacific COPD & Asthma Devices Market 2016-2022: Degrading Air Quality Near the Industrial Areas Increases Incidences of Asthma - Research and Markets

Research and Markets
Posted on: 23 Nov 16

Research and Markets has announced the addition of the "Asia Pacific COPD & Asthma Devices Market (2016-2022)" report to their offering.

Asia Pacific is expected to be the fastest regional market for asthma and COPD devices owing to the increased incidence of asthma & other respiratory diseases in industrial regions.

The Asia Pacific market for Asthma & COPD has been analyzed on the basis of drugs and devices used for these diseases. Key drugs employed for control and diagnosis of asthma and COPD may be classified on the basis of their types which include bronchodilators, leukotriene antagonists, mast cell stabilizers and immunosuppressants.

Degrading air quality near the industrial areas has led to the increased incidence of asthma especially in the low-income population in the emerging economies. Increasing disposable income levels in emerging economies as well as developing countries has led to the increased usage of asthma pumps and sprays in these regions.

The report highlights the adoption of COPD & Asthma Devices in Asia Pacific. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Asia Pacific.

Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.

Key Topics Covered:

1. Market Scope & Methodology

2. Asia Pacific COPD and Asthma Devices Market Overview

3. Asia Pacific COPD and Asthma Device Market - By Product Type

4. Asia Pacific COPD & Asthma Devices Market - By Country

5. Company Profiles

- Glaxosmithcline PLC

- Novartis International AG

- Merck & Co., Inc.

- AstraZeneca Plc

- 3M Healthcare

- GF Health Products, Inc

- Sunovion Pharmaceuticals Inc.

- Koninklijke Philips N.V.

- Smith Medicals, Inc.

- Baxter International

For more information about this report visit http://www.researchandmarkets.com/research/hzz7vv/asia_pacific_copd

View source version on businesswire.com: http://www.businesswire.com/news/home/20161123005334/en/

Business Wire
www.businesswire.com

Last updated on: 23/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.